Teva Settles Suit Over Watson’s Generic LoSeasonique

Law360, New York (December 12, 2011, 1:51 PM EST) -- Teva Women’s Health Inc. on Thursday settled a patent infringement suit in New Jersey over Watson Pharmaceuticals Inc.’s bid to market a generic version of Teva’s oral contraceptive LoSeasonique.

U.S. District Judge Claire C. Cecchi signed off on a joint stipulation to dismiss the suit with prejudice, saying both parties had agreed to drop claims and counterclaims related to Watson’s plans to produce a generic version of LoSeasonique.

Under the provisions of the settlement agreement, Watson was able to launch its Amethia Lo tablets, the generic...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.